|
Volumn 12, Issue 5, 2012, Pages 361-362
|
Lyme disease antiscience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACCREDITATION;
ANTIBIOTIC THERAPY;
AWARENESS;
BACTERIUM ISOLATE;
BORRELIA BURGDORFERI;
BORRELIA INFECTION;
CLINICAL RESEARCH;
EVIDENCE BASED MEDICINE;
HEALTH CARE ORGANIZATION;
HUMAN;
LETTER;
LYME DISEASE;
MEDICAL EXPERT;
MEDICINE;
NATIONAL HEALTH SERVICE;
PEER REVIEW;
PHYSICIAN;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SEROLOGY;
SYMPTOM;
UNCERTAINTY;
UNITED KINGDOM;
CONSUMER ADVOCACY;
ETHICS;
NOTE;
PROFESSIONAL MISCONDUCT;
ANTIINFECTIVE AGENT;
ANTI-BACTERIAL AGENTS;
BORRELIA BURGDORFERI;
CONSUMER ADVOCACY;
HUMANS;
LYME DISEASE;
PHYSICIANS;
PROFESSIONAL MISCONDUCT;
|
EID: 84860301206
PISSN: 14733099
EISSN: 14744457
Source Type: Journal
DOI: 10.1016/S1473-3099(12)70053-1 Document Type: Letter |
Times cited : (3)
|
References (6)
|